RA 9165 Flashcards
Criminal Liability of a Public Officer or Employee for Misappropriation, Misapplication or Failure to Account for the Confiscated, Seized and/or Surrendered Dangerous Drugs, Plant Sources of Dangerous Drugs, Controlled Precursors and Essential Chemicals, Instruments/Paraphernalia and/or Laboratory Equipment Including the Proceeds or Properties Obtained from the Unlawful Act Committed
The penalty of life imprisonment to death and a fine ranging from Five hundred thousand pesos (P500,000.00) to Ten million pesos (P10,000,000.00), in addition to absolute perpetual disqualification from any public office
Elective local or national official found to have benefited from the proceeds of the trafficking of dangerous drugs, or have received any financial or material contributions or donations from natural or juridical persons found guilty of trafficking dangerous drugs
Removed from office and perpetually disqualified from holding any elective or appointive positions in the government
Criminal Liability for Planting of Evidence
Penalty of death
Responsibility and Liability of Law Enforcement Agencies and other Government Officials and Employees in Testifying as Prosecution Witnesses in Dangerous Drugs Cases
Failure/refusal to appear as witness:
Imprisonment of not less than twelve (12) years and one (1) day to twenty (20) years and a fine of not less than Five hundred thousand pesos (P500,000.00)
Failure of supervisor to exert effort to present the witness
NLT 2 year 1 day - 6 years
50k
Failure of supervisor to notify court of transfer
2 yr 1 day - 6 yr
10k - 50k
Additonal: Disqualification from public office
Delay and Bungling in the Prosecution of Drug Cases
12 yrs 1 day - 20 yrs
Grant of Compensation, Reward and Award
1k - 2M per successful drug op
Small scale clandestine laboratory
<10kg/batch
150k
Computed reward under operation LAWMEN
Medium scale clandestine laboratory
10kg-50kg/batch
1 million
Computed reward under operation LAWMEN
Large scale clandestine laboratory
50kg/batch
1.5 million
Computed reward under operation LAWMEN
Records Required for Transactions on Dangerous Drug and Precursors and Essential Chemicals
A certified true copy covering a period of six (6) months, shall be forwarded to the Board within fifteen (15) days following the last day of June and December of each year
One (1) original and two (2) duplicate copies.
Original - Pharmacist
Duplicate -Patient
Triplicate - Prescriber
the policy-making and strategy-formulating body in the planning and formulation of policies and programs on drug prevention and control.
Dangerous Drug Board
DDB
It shall develop and adopt a comprehensive, integrated, unified and balanced national drug abuse prevention and control strategy.
It shall be under the Office of the President.
Composition of DDB
Composed of seventeen (17) members
- three (3) of which are permanent members
- twelve (12) members shall be in an ex officio capacity
- two (2) shall be regular members.
- twelve (12) members who shall be ex officio members of the Board
- Two (2) regular members of:
(a) The president of the Integrated Bar of the Philippines
(b) The chairman or president of a non-government organization involved in dangerous drug campaign
The implementing arm of the Board, and shall be responsible for the efficient and effective law enforcement of all the provisions on any dangerous drug and/or controlled precursor and essential chemical
Philippine Drug Enforcement Agency (PDEA)
PDEA Head
Director-general (Undersec)
PDEA Academy
- Established in Baguio or Tagaytay City
- Responsible in the recruitment and training
- Qualifications and requirements: 21 years old, of proven **integrity **and honesty and a Baccalaureate degree holder
- Graduates: Operating units of the PDEA after the termination of the transition period of five (5) years
- Headed by a Superintendent, with the rank of Director. He/she shall be appointed by the PDEA Director General.
License issued for Retail of DPs containing Table I CC
S1
License issued for Retail of DD/DDPs/DPs containing Table I CC
S3
License issued for Wholesale/Distribution of of DDs/DDPs/DPs containing Table I CC used in manufactur of drug preparations
S4
C Compounding/Manufacture of DD/DDPs/DPs containing Table I CC
S5
License issued for Importation of DDs/DDPs/DPs containing Table I CC used in manufactur of drug preparations
S5I
License issued for Exportation of DDs/DDPs/DPs containing Table I CC used in manufactur of drug preparations
S5E
License issued for Depot/Storage for S4, S5 License holder
S-5D
License issued to conduct laboratory analysis or technical research using DDs/DDPs/DPs
S-6
License to prescribed DDs/DDPs/DPs containing Table I CC
S-2
License to sell, procure, acquire, deal in, specified CPECs or its preparations for retail purpose
P1
End-user of specified CPECs
P3
Wholesale distribution of SPECs
P4
License to import CPECs
P-5-I
Importer
License to manufacture or recycle specified CPECs
P-5C
License to export specified CPECs and its preparations
P-5E
License for bulk depot/storage of CPECs
P-5D
License to bring CPECs into the Philippines in transit or transship
P-5-B
License to import specified CPECs or its preparations, as End-user
P-5IM
License to deal with or transact matters involving CPECs as brokerage firms, entities, or individual broker
P-7
License to acquire CPECs for conducting laboratory analysis for technical research or instructional/training programs
S-6 or P-6
Validity of PDEA Licenses
1 years except S2 license for 3 years
Renewal of PDEA Licenses
3 months prior expiration
S licenses shall remain for _______ for first time license holde and _____ for qualified renewal license holders
S licenses shall remain for 1 year for first time license holde and 3 years for qualified renewal license holders
Threshold for Acetone
RA 9165: 1L
Amended: 5L
Threshold for H2SO4
RA 9165: 25L
Amended: 25L
Prescription Limit for Morphine Sulfate
Tab: 3000mg
Ampoule: 448 mg
Prescription Limit for Oxycontin
1,200mg
10mg: 120 tablets
20mg: 100 tablets
40mg: 30 tablets
80mg: 15 tabs
